INS and gestational diabetes: A meta-analysis using data from RCTs comparing metformin with insulin in GDM showed that metformin decreases birthweight but leads to accelerated postnatal growth, ultimately resulting in increased childhood adiposity, warranting concerns into long-term metabolic consequences for offspring [5].